2024 Nifedipine Trends Analysis, China Nifedipine Industry Research and Trends Forecast Report 2021-2027

返回首頁|排行榜|聯(lián)系我們|服務(wù)流程|繁體中文

訂閱Rss更新 下載電子版產(chǎn)業(yè)調(diào)研網(wǎng) > 調(diào)研報告 > 醫(yī)藥保健行業(yè) > China Nifedipine Industry Research and Trends Forecast Report 2021-2027

China Nifedipine Industry Research and Trends Forecast Report 2021-2027

報告編號：3165230 ┊ 產(chǎn)業(yè)調(diào)研網(wǎng) CIR.cn ┊ 推薦：

名　稱：China Nifedipine Industry Research and Trends Forecast Report 2021-2027
編　號：3165230　
市場價：電子版23300元　　紙質(zhì)+電子版24300元
優(yōu)惠價：電子版22300元　　紙質(zhì)+電子版22600元
電　話：400 612 8668、010-6618 1099、66182099、66183099
郵　箱：KF@Cir.cn　　《訂購協(xié)議》下載
提　示：如需中文、日文等其他語言版本，請與我們聯(lián)系。
網(wǎng)上訂購　　下載訂購協(xié)議　　 Pdf格式下載

China Nifedipine Industry Research and Trends Forecast Report 2021-2027

字號：小中大報告內(nèi)容：

1 Introduction to Research & Analysis Reports

　1.1 Nifedipine Market Definition

　1.2 Market Segments

　　1.2.1 Segment by Type

　　1.2.2 Segment by Application

　1.3 China Nifedipine Market Overview

　1.4 Methodology & Sources of Information

　　1.4.1 Research Methodology

　　1.4.2 Research Process

　　1.4.3 Base Year

2 China Nifedipine Overall Market Size

　2.1 China Nifedipine Market Size: 2021 VS 2027

　2.2 China Nifedipine Revenue, Prospects & Forecasts: 2016-2027

　2.3 China Nifedipine Sales: 2016-2027

3 Company Landscape

　3.1 Top Nifedipine Players in China Market

　3.2 Top China Nifedipine Companies Ranked by Revenue

　3.3 China Nifedipine Revenue by Companies

　3.4 China Nifedipine Sales by Companies

　3.5 China Nifedipine Price by Manufacturer (2016-2021)

　3.6 Top 3 and Top 5 Nifedipine Companies in China Market, by Revenue in 2020

　3.7 Manufacturers Nifedipine Product Type

　3.8 Tier 1, Tier 2 and Tier 3 Nifedipine Players in China Market

詳情：http://www.miaohuangjin.cn/0/23/China-Nifedipine-Industry-Research-and-Trends-Forecast-Report-2021-2027.html

　　3.8.1 List of Tier 1 Nifedipine Companies in China

　　3.8.2 List of Tier 2 and Tier 3 Nifedipine Companies in China

4 Sights by Type

　4.1 Overview

　　4.1.1 By Type - China Nifedipine Market Size Markets, 2021 & 2027

　　4.1.2 Nifedipine Controlled Release Tablets

　　4.1.3 Nifedipine Extended Action Tablets

　4.2 By Type - China Nifedipine Revenue & Forecasts

　　4.2.1 By Type - China Nifedipine Revenue, 2016-2021

　　4.2.2 By Type - China Nifedipine Revenue, 2022-2027

　　4.2.3 By Type - China Nifedipine Revenue Market Share, 2016-2027

　4.3 By Type - China Nifedipine Sales & Forecasts

　　4.3.1 By Type - China Nifedipine Sales, 2016-2021

　　4.3.2 By Type - China Nifedipine Sales, 2022-2027

　　4.3.3 By Type - China Nifedipine Sales Market Share, 2016-2027

　4.4 By Type - China Nifedipine Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

　5.1 Overview

　　5.1.1 By Application - China Nifedipine Market Size, 2021 & 2027

　　5.1.2 Primary Pulmonary Hypertension

　　5.1.3 Heart Failure

　　5.1.4 Others

　5.2 By Application - China Nifedipine Revenue & Forecasts

　　5.2.1 By Application - China Nifedipine Revenue, 2016-2021

　　5.2.2 By Application - China Nifedipine Revenue, 2022-2027

　　5.2.3 By Application - China Nifedipine Revenue Market Share, 2016-2027

　5.3 By Application - China Nifedipine Sales & Forecasts

　　5.3.1 By Application - China Nifedipine Sales, 2016-2021

　　5.3.2 By Application - China Nifedipine Sales, 2022-2027

　　5.3.3 By Application - China Nifedipine Sales Market Share, 2016-2027

　5.4 By Application - China Nifedipine Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

　6.1 Bayer

　　6.1.1 Bayer Corporation Information

　　6.1.2 Bayer Overview

　　6.1.3 Bayer Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.1.4 Bayer Nifedipine Product Description

　　6.1.5 Bayer Recent Developments

　6.2 Actavis

　　6.2.1 Actavis Corporation Information

　　6.2.2 Actavis Overview

　　6.2.3 Actavis Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.2.4 Actavis Nifedipine Product Description

　　6.2.5 Actavis Recent Developments

　6.3 Teva

　　6.3.1 Teva Corporation Information

中國硝苯地平工業(yè)研究與趨勢預(yù)測報告2021 - 2010年

　　6.3.2 Teva Overview

　　6.3.3 Teva Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.3.4 Teva Nifedipine Product Description

　　6.3.5 Teva Recent Developments

　6.4 Pfizer

　　6.4.1 Pfizer Corporation Information

　　6.4.2 Pfizer Overview

　　6.4.3 Pfizer Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.4.4 Pfizer Nifedipine Product Description

　　6.4.5 Pfizer Recent Developments

　6.5 Shyndec

　　6.5.1 Shyndec Corporation Information

　　6.5.2 Shyndec Overview

　　6.5.3 Shyndec Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.5.4 Shyndec Nifedipine Product Description

　　6.5.5 Shyndec Recent Developments

　6.6 Honglin

　　6.6.1 Honglin Corporation Information

　　6.6.2 Honglin Overview

　　6.6.3 Honglin Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.6.4 Honglin Nifedipine Product Description

　　6.6.5 Honglin Recent Developments

　6.7 Huanghai

　　6.7.1 Huanghai Corporation Information

　　6.7.2 Huanghai Overview

　　6.7.3 Huanghai Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.7.4 Huanghai Nifedipine Product Description

　　6.7.5 Huanghai Recent Developments

　6.8 Yabao

　　6.8.1 Yabao Corporation Information

　　6.8.2 Yabao Overview

　　6.8.3 Yabao Nifedipine Sales and Revenue in China Market (2016-2021)

　　6.8.4 Yabao Nifedipine Product Description

　　6.8.5 Yabao Recent Developments

7 China Nifedipine Production Capacity, Analysis

　7.1 China Nifedipine Production Capacity, 2016-2027

　7.2 Nifedipine Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

　8.1 Market Opportunities & Trends

　8.2 Market Drivers

　8.3 Market Restraints

9 Nifedipine Supply Chain Analysis

　9.1 Nifedipine Industry Value Chain

中國硝苯地平工業(yè)研究與趨勢預(yù)測報告2021 - 2010年

　9.2 Nifedipine Upstream Market

　9.3 Nifedipine Downstream and Clients

　9.4 Marketing Channels Analysis

　　9.4.1 Marketing Channels

　　9.4.2 Nifedipine Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

　11.1 Note

　11.2 Examples of Clients

　11.3 Author Details

　11.4 Disclaimer

List of Tables

　Table 1. Key Players of Nifedipine in China Market

　Table 2. Top Nifedipine Players in China Market, Ranking by Revenue (2019)

　Table 3. China Nifedipine Revenue by Companies, (US$, Mn), 2016-2021

　Table 4. China Nifedipine Revenue Share by Companies, 2016-2021

　Table 5. China Nifedipine Sales by Companies, (MT), 2016-2021

　Table 6. China Nifedipine Sales Share by Companies, 2016-2021

　Table 7. Key Manufacturers Nifedipine Price (2016-2021) & (USD/Kg)

　Table 8. Manufacturers Nifedipine Product Type

　Table 9. List of Tier 1 Nifedipine Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 10. List of Tier 2 and Tier 3 Nifedipine Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 11. Major Manufacturers of Nifedipine Controlled Release Tablets

　Table 12. Major Manufacturers of Nifedipine Extended Action Tablets

　Table 13. By Type – China Nifedipine Revenue, (US$, Mn), 2021 & 2027

　Table 14. By Type - China Nifedipine Revenue (US$, Mn), 2016-2021

　Table 15. By Type - China Nifedipine Revenue (US$, Mn), 2022-2027

　Table 16. By Type - China Nifedipine Sales (MT), 2016-2021

　Table 17. By Type - China Nifedipine Sales (MT), 2022-2027

　Table 18. By Application – China Nifedipine Revenue, (US$, Mn), 2021 VS 2027

　Table 19. By Application - China Nifedipine Revenue (US$, Mn), 2016-2021

　Table 20. By Application - China Nifedipine Revenue (US$, Mn), 2022-2027

　Table 21. By Application - China Nifedipine Sales (MT), 2016-2021

　Table 22. By Application - China Nifedipine Sales (MT), 2022-2027

　Table 23. Bayer Corporation Information

　Table 24. Bayer Description and Major Businesses

　Table 25. Bayer Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 26. Bayer Nifedipine Product

　Table 27. Bayer Recent Developments

　Table 28. Actavis Corporation Information

　Table 29. Actavis Description and Major Businesses

　Table 30. Actavis Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 31. Actavis Nifedipine Product

　Table 32. Actavis Recent Developments

　Table 33. Teva Corporation Information

zhōngguó xiāo běn dìpíng gōngyè yánjiū yǔ qūshì yùcè bàogào 2021 - 2010 nián

　Table 34. Teva Description and Major Businesses

　Table 35. Teva Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 36. Teva Nifedipine Product

　Table 37. Teva Recent Developments

　Table 38. Pfizer Corporation Information

　Table 39. Pfizer Description and Major Businesses

　Table 40. Pfizer Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 41. Pfizer Nifedipine Product

　Table 42. Pfizer Recent Developments

　Table 43. Shyndec Corporation Information

　Table 44. Shyndec Description and Major Businesses

　Table 45. Shyndec Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 46. Shyndec Nifedipine Product

　Table 47. Shyndec Recent Developments

　Table 48. Honglin Corporation Information

　Table 49. Honglin Description and Major Businesses

　Table 50. Honglin Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 51. Honglin Nifedipine Product

　Table 52. Honglin Recent Developments

　Table 53. Huanghai Corporation Information

　Table 54. Huanghai Description and Major Businesses

　Table 55. Huanghai Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 56. Huanghai Nifedipine Product

　Table 57. Huanghai Recent Developments

　Table 58. Yabao Corporation Information

　Table 59. Yabao Description and Major Businesses

　Table 60. Yabao Nifedipine Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)

　Table 61. Yabao Nifedipine Product

　Table 62. Yabao Recent Developments

　Table 63. Nifedipine Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT)

　Table 64. China Nifedipine Capacity Market Share of Key Manufacturers, 2019-2021

　Table 65. Nifedipine Market Opportunities & Trends in China Market

　Table 66. Nifedipine Market Drivers in China Market

　Table 67. Nifedipine Market Restraints in China Market

　Table 68. Nifedipine Raw Materials

　Table 69. Nifedipine Raw Materials Suppliers in China Market

　Table 70. Typical Nifedipine Downstream

　Table 71. Nifedipine Downstream Clients in China Market

　Table 72. Nifedipine Distributors and Sales Agents in China Market

List of Figures

　Figure 1. Nifedipine Product Picture

　Figure 2. Nifedipine Segment by Type

　Figure 3. Nifedipine Segment by Application

　Figure 4. China Nifedipine Market Overview: 2020

　Figure 5. China Nifedipine Market Size: 2021 VS 2027 (US$, Mn)

中國ニフェジピン業(yè)界の研究とトレンド予測報告書2021-2027

　Figure 6. China Nifedipine Revenue, 2016-2027 (US$, Mn)

　Figure 7. Nifedipine Sales in China Market: 2016-2027 (MT)

　Figure 8. The Top 3 and 5 Players Market Share by Nifedipine Revenue in 2020

　Figure 9. Nifedipine Controlled Release Tablets Product Picture

　Figure 10. Nifedipine Extended Action Tablets Product Picture

　Figure 11. By Type - China Nifedipine Sales Market Share, 2016-2027

　Figure 12. By Type - China Nifedipine Revenue Market Share, 2016-2027

　Figure 13. By Type - China Nifedipine Price (USD/Kg), 2016-2027

　Figure 14. Primary Pulmonary Hypertension

　Figure 15. Heart Failure

　Figure 16. Others

　Figure 17. By Application - China Nifedipine Sales Market Share, 2016-2027

　Figure 18. By Application - China Nifedipine Revenue Market Share, 2016-2027

　Figure 19. By Application - China Nifedipine Price (USD/Kg), 2016-2027

　Figure 20. Bayer Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 21. Actavis Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 22. Teva Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 23. Pfizer Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 24. Shyndec Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 25. Honglin Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 26. Huanghai Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 27. Yabao Nifedipine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 28. China Nifedipine Production Capacity (MT), 2016-2027

　Figure 29. Nifedipine Industry Value Chain

　Figure 30. Marketing Channels

　　http://www.miaohuangjin.cn/0/23/China-Nifedipine-Industry-Research-and-Trends-Forecast-Report-2021-2027.html

　　產(chǎn)業(yè)調(diào)研網(wǎng)

　　…

掃一掃 “China Nifedipine Industry Research and Trends Forecast Report 2021-2027”

如需購買《China Nifedipine Industry Research and Trends Forecast Report 2021-2027》，編號：3165230
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn　　【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”

咨詢熱線：400 612 8668、010-6618 1099、010-66182099、010-66183099　咨詢郵箱：KF@Cir.cn

京ICP備10007914號-8　京公網(wǎng)安備 11010802027365號